Cited by 231Endoplasmic Reticulum Stress and DiseaseCancer, Hypoxia, and MetabolismCell death mechanisms and regulation

ER Stress, Hypoxia Tolerance and Tumor Progression

Koumenis, Constantinos·2006·Current Molecular Medicine

Abstract

The development of chronic and fluctuating hypoxic regions in tumors has profound consequences for malignant progression, response to therapy and overall patient survival. Understanding the events involved in hypoxia tolerance will offer new opportunities for antitumor modalities. A universal response of tumor cells to hypoxia is a rapid and substantial decrease in the rates of macromolecular synthesis. Hypoxia induces phosphorylation of the translation initiation factor eIF2alpha on Ser51 via activation of the endoplasmic reticulum (ER) resident kinase PERK and that this modification is required for the rapid downregulation of global protein synthesis by this hypoxic stress. PERK-dependent phosphorylation of eIF2alpha is one component of the Unfolded Protein Response (UPR), a coordinated program that promotes cell survival under conditions of ER stress. Inactivation of PERK or eIF2alpha phosphorylation impairs cell survival under hypoxia, and transformed cells with inactivating PERK or eIF2alpha mutations form tumors in nude mice that are slower growing, and have higher levels of apoptosis in hypoxic areas compared to tumors with an intact UPR. Expression of the transcription factor ATF4, a downstream effector of eIF2alpha phosphorylation, is also upregulated by hypoxia in vitro and in human tumors and increases hypoxia tolerance. A second UPR pathway mediated by activation of IRE1 and its downstream target XBP1 is also required for hypoxia tolerance in vitro and for tumor growth. These results reveal a critical role for UPR activation for tumor cell resistance to hypoxia and tumor growth promotion and suggest that the UPR may be an attractive target for anti-tumor modalities.

Integrity signals

Registry

Crossref · 10.2174/156652406775574604

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Folding capacity may be compromised if oxygen or ATP concentrations are limiting, but this is likely a secondary mechanism.

    “Folding capacity may therefore be compromised if oxygen or ATP concentrations are limiting, but this is likely to be a secondary mechanism (315).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [315]

Cited by

Sorted by citations

Authors
Koumenis, C.
Affiliations
Wake Forest University Health Sciences (US)
Corresponding author
Koumenis, Constantinos
Venue
Current Molecular Medicine
Published
2006-02-01
Volume
6
Issue
1
Pages
55-69
ISSN
1566-5240 (ISSN-L)
OpenAlex
W2000859982
Cited by
231
References
0
Citations by year
2026: 4 · 2025: 3 · 2024: 7 · 2023: 11 · 2022: 6 · 2021: 4 · 2020: 12 · 2019: 8 · 2018: 7 · 2017: 8 · 2016: 14 · 2015: 20 · 2014: 19 · 2013: 16 · 2012: 15
FWCI
7.04
Type
journal article
Language
en
Open access
closed
Locations
  • Current Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01 CA94214, R01CA094214)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
endoplasmic reticulum stress, hypoxia tolerance, tumor progression, unfolded protein response, PERK, eIF2α phosphorylation, ATF4, IRE1, XBP1, tumor hypoxia, apoptosis
MeSH terms
Animals, Endoplasmic Reticulum, Humans, Neoplasms, Cell Hypoxia, Protein Folding, Disease Progression, eIF-2 Kinase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review